PH12020500246A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
PH12020500246A1
PH12020500246A1 PH12020500246A PH12020500246A PH12020500246A1 PH 12020500246 A1 PH12020500246 A1 PH 12020500246A1 PH 12020500246 A PH12020500246 A PH 12020500246A PH 12020500246 A PH12020500246 A PH 12020500246A PH 12020500246 A1 PH12020500246 A1 PH 12020500246A1
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
active ingredient
compositions
medicine
buffer
Prior art date
Application number
PH12020500246A
Other languages
English (en)
Inventor
Gary Cook
Sally Louise Marsh
Stephen John Pethen
Michael Bryan Roe
Christopher Martyn Yea
Original Assignee
Kalvista Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1713660.7A external-priority patent/GB201713660D0/en
Application filed by Kalvista Pharmaceuticals Ltd filed Critical Kalvista Pharmaceuticals Ltd
Publication of PH12020500246A1 publication Critical patent/PH12020500246A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
PH12020500246A 2017-08-11 2020-02-03 Pharmaceutical compositions PH12020500246A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762544346P 2017-08-11 2017-08-11
GBGB1713660.7A GB201713660D0 (en) 2017-08-25 2017-08-25 Pharmaceutical compositions
PCT/GB2018/052292 WO2019030540A1 (en) 2017-08-11 2018-08-13 PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
PH12020500246A1 true PH12020500246A1 (en) 2021-03-15

Family

ID=70976595

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12020500246A PH12020500246A1 (en) 2017-08-11 2020-02-03 Pharmaceutical compositions

Country Status (8)

Country Link
CL (1) CL2020000356A1 (es)
CO (1) CO2020002287A2 (es)
EC (1) ECSP20017939A (es)
IL (1) IL272428A (es)
MX (1) MX2020001356A (es)
PH (1) PH12020500246A1 (es)
RU (1) RU2020109955A (es)
UA (1) UA125537C2 (es)

Also Published As

Publication number Publication date
MX2020001356A (es) 2020-03-20
CO2020002287A2 (es) 2020-06-09
RU2020109955A (ru) 2021-09-14
IL272428A (en) 2020-03-31
CL2020000356A1 (es) 2020-06-19
ECSP20017939A (es) 2020-04-22
RU2020109955A3 (es) 2022-01-24
UA125537C2 (uk) 2022-04-13

Similar Documents

Publication Publication Date Title
NI201900041A (es) 1, 2, 4-triazolonas 2, 4, 5-trisustituidas
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
CO2020001244A2 (es) Derivados de quinolina para tratar infecciones con helmintos
CR20170411A (es) Composiciones farmacéuticas que comprenden n-(3,5-dimetoxifenil)-n-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il-quin oxalin-6-il]etano-1,2-diamina
CR20210201A (es) Nuevos compuestos antihelmínticos
MX368504B (es) Derivados de amidas y sales farmaceuticamente aceptables de los mismos, método de preparación de los mismos y aplicación médica de los mismos.
PE20191650A1 (es) Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
MX2018000285A (es) Composicion para desobstruir la nariz congestionada que tiene actividad antiviral.
TN2019000204A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
CL2020002252A1 (es) Formulación oftálmica.
MY163235A (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
MY197518A (en) Preventive and/or therapeutic agent of immune disease
EA202190317A1 (ru) Лекарственный препарат для наружного применения
PH12020500246A1 (en) Pharmaceutical compositions
JOP20180071B1 (ar) استخدام مشتقات أمينو ألكيل بنزوثيازبين
MX2023006235A (es) Composiciones para administracion de farmacos y metodos de uso de las mismas.
MX2022006502A (es) Composiciones farmaceuticas.
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
RU2015137671A (ru) Профилактическое или терапевтическое лекарственное средство для лечения запора
MX2016004464A (es) Derivados novedosos de pradimicina para el tratamiento de enfermedades provocadas por kinetoplastidos.